EVMT — Evome Medical Technologies Share Price
0.000.00%
Last trade - 00:00- CA$17.48m
- CA$41.25m
- CA$62.63m
- 50
- 43
- 48
- 44
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.37 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.28 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -183.81% | ||
| Return on Equity | -161.4% | ||
| Operating Margin | -31.37% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | 1.26 | 0.4 | 0.15 | 18.31 | 62.63 | 62.21 | 74.47 | 73.89% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Evome Medical Technologies Inc. is an international medical device company, which is focused on human performance and rehabilitative solutions. The Company’s products include Biodex Rehab product, Damar Plastics product, Mio-Guard product, Simbex services, and SDP product. Its Biodex Rehab products include Isokinetic Systems, Gait Trainer, Body-Weight Supported Training, Cycles and Ergometers, and Squat-Assist Trainer. Its Mio-Guard products include bags, cases and kits, braces, and supports, diagnostics and instruments, furniture, and equipment, padding and splinting, personal protection, sanitizers and disinfectants, and tapes and wraps. Its applications include fall risk screening and conditioning, patient-driven payment model (PDPM), wellness, sports medicine solutions, neurological involvement, safe patient handling and mobility, and senior living and rehabilitation. It offers concussion, fall screening and balance assessment and training programs.
Directors
- Leslie Cross CHM (70)
- Jane Kiernan NVC (60)
- Melissa Polesky-meyrowitz CFO
- Luke Faulstick COO (57)
- Kenneth Kashkin NID (70)
- Kyle Wilks NID (44)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- July 7th, 2015
- Public Since
- March 28th, 2014
- No. of Shareholders
- 41
- No. of Employees
- 195
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- TSX Venture Exchange
- Shares in Issue
- 85,273,730
- Address
- 49 Natcon Drive, SHIRLEY, 11967-4704
- Web
- https://www.evomemedical.com/
- Phone
- Auditors
- SRCO Professional Corporation
Upcoming Events for EVMT
Similar to EVMT
Aurora Spine
TSX Venture Exchange
CardioComm Solutions
TSX Venture Exchange
Cloud DX
TSX Venture Exchange
Enablence Technologies
TSX Venture Exchange
EvokAI Creative Labs
TSX Venture Exchange
FAQ
What is the Evome Medical Technologies share price?
As of Today at 19:08 UTC, shares in Evome Medical Technologies are trading at CA$0.21. This share price information is delayed by 15 minutes.
How has the Evome Medical Technologies share price performed this year?
Shares in Evome Medical Technologies last closed at CA$0.21 and the price had moved by -35% over the past 365 days. In terms of relative price strength the Evome Medical Technologies share price has underperformed the Toronto Stock Exchange 300 Composite Index by -38.71% over the past year.
What are the analyst and broker recommendations for Evome Medical Technologies?
The overall consensus recommendation for Evome Medical Technologies is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Evome Medical Technologies dividend yield?
Evome Medical Technologies does not currently pay a dividend.
Does Evome Medical Technologies pay a dividend?
Evome Medical Technologies does not currently pay a dividend.
When does Evome Medical Technologies next pay dividends?
Evome Medical Technologies does not currently pay a dividend.
How do I buy Evome Medical Technologies shares?
To buy shares in Evome Medical Technologies you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Evome Medical Technologies?
As of the previous close price of CA$0.21, shares in Evome Medical Technologies had a market capitalisation of CA$17.48m.
Where are Evome Medical Technologies shares listed?
Here are the trading details for Evome Medical Technologies:
- Country of listing: Canada
- Exchange: CVE
- Ticker Symbol: EVMT
What kind of share is Evome Medical Technologies?
Based on an overall assessment of its quality, value and momentum Evome Medical Technologies is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Evome Medical Technologies share price forecast for 2024?
The analyst consensus target price for shares in Evome Medical Technologies is CA$1.15. That is 460.98% above the last closing price of CA$0.21.
Analysts covering Evome Medical Technologies currently have a consensus Earnings Per Share (EPS) forecast of -CA$0.05 for the next financial year.
What is the trend in the Evome Medical Technologies share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Evome Medical Technologies. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -23.63%.
As of the last closing price of CA$0.21, shares in Evome Medical Technologies were trading -9.61% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Evome Medical Technologies PE Ratio?
The Evome Medical Technologies PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.21.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Evome Medical Technologies?
Evome Medical Technologies' management team is headed by:
- Leslie Cross - CHM
- Jane Kiernan - NVC
- Melissa Polesky-meyrowitz - CFO
- Luke Faulstick - COO
- Kenneth Kashkin - NID
- Kyle Wilks - NID